Home 📚BioDBS Bibliography database[Title] Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database

Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database

database[Title] 2026-06-27

Summary:

CONCLUSION: This study provides safety data on the use of ipilimumab in elderly patients and suggests prioritizing monitoring for gastrointestinal events and endocrine toxicities in elderly patients during treatment.

Link:

https://pubmed.ncbi.nlm.nih.gov/42318455/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20260627033548&v=2.20.0

From feeds:

📚BioDBS Bibliography » database[Title]

Tags:

Authors:

Yang Yang, Fang Wang, Weijia Tong, Xinglan Lu, Feng Zhao, Shencun Fang, Shiqiao Wang

Date tagged:

06/27/2026, 03:45

Date published:

06/19/2026, 06:00